Skip to content

The Predictors for Asthma Control by Stepwise Treatment During 6 Months in Korean Elderly

The Predictors for Asthma Control by Stepwise Treatment During 6 Months in Korean Elderly

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01370577
Acronym
Prelude
Enrollment
297
Registered
2011-06-10
Start date
2011-07-31
Completion date
2012-11-30
Last updated
2013-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

Predictors for asthma control, Asthma Exacerbation rate, Mean frequency of PFT, sputum assessments, refill adherence(%), prescription persistence

Brief summary

The Predictors for asthma control by stepwise treatment during 6 months in Korean elderly

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged 60 years or more, articulate in Korean * Patients diagnosed with asthma, at least 1 year in duration.

Exclusion criteria

* Patients being followed-up for asthma treatment less than 1 year before baseline * Patients taking immune therapy * Patients previously enrolled/randomized in the present clinical trial

Design outcomes

Primary

MeasureTime frame
Baseline characteristics related to asthma control in the elderly6 months
Asthma exacerbation rate of the elderly during guideline-based stepwise treatments6 months

Secondary

MeasureTime frame
1. Proportion of controlled, partially controlled, and controlled patients among the elderly patients with asthma in Korea6 months
2. Baseline characteristics related to asthma specific QOL in the elderly patients with asthma6 months
Mean frequency of PFT, sputum assessments, refill adherence(%), prescription persistence in elderly asthma for the last 1 year before study enrollment6 months

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026